Urosepsis: How much do we really know?

Panagiotis Mourmouris, T Markopoulos, M Mperdempes, Andreas Skolarikos

Abstract


Sepsis, a syndrome of physiologic, pathologic and biochemical
abnormalities induced by infection, is a major public health
concern and its incidence is increasing worldwide. Urosepsis represents
an approximately 25% of all sepsis cases and it requires
a multi-disciplinary team consisted by urologists, intensive care
and infectious diseases specialists. We review the literature for
potential changes in the steps of recognition and management
of this life-threatening syndrome in an effort to widen our
knowledge and minimize the risk of complications of sepsis.


Keywords


Sepsis; septic shock;definition;management;complications

Full Text:

PDF

References


Torio CM, Andrews RM, [Accessed October 31, 2015] National

inpatient hospital costs: the most expensive conditions by payer,

Statistical Brief #160. Healthcare Cost and Utilization Project

(HCUP) Statistical Briefs. 2013 Aug. http://www.ncbi.nlm.nih.gov/

books/NBK169005/.

Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden

of long-term survivorship after severe sepsis in older Americans.

J Am Geriatr Soc. 2012; 60(6):1070–1077.

Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the

incidence and mortality of severe sepsis in the United States. Crit

Care Med. 2013; 41(5):1167–1174.

Vincent J-L, Marshall JC, Namendys-Silva SA, et al. ICON Investigators.

Assessment of the worldwide burden of critical illness:

the Intensive Care Over Nations (ICON) audit. Lancet Respir Med.

; 2(5):380–386. [PubMed: 24740011].

Fleischmann C, Scherag A, Adhikari NK, et al. International Forum of

Acute Care Trialists. Assessment of global incidence and mortality

of hospital-treated sepsis: current estimates and limitations. Am

J Respir Crit Care Med. 2015.

Bone RC, Balk RA, Cerra FB, et al. American College of Chest Physicians/

Society of Critical Care Medicine Consensus Conference:

definitions for sepsis and organ failure and guidelines for the use of

innovative therapies in sepsis. Crit Care Med. 1992; 20(6):864–874.

Levy MM, Fink MP, Marshall JC, et al. International Sepsis Definitions

Conference. 2001 SCCM/ ESICM/ACCP/ATS/SIS International Sepsis

Definitions Conference. Intensive Care Med. 2003;29(4):530–538.

[PubMed: 12664219].

Wagenlehner FM1, Pilatz A, Naber KG, Weidner W. Therapeutic

challenges of urosepsis Eur J Clin Invest. 2008 Oct;38 Suppl 2:45-9.

Singer, M., et al. The Third International Consensus Definitions for

Sepsis and Septic Shock (Sepsis-3). JAMA, 2016. 315: 801.

Vincent JL, Moreno R, Takala J, et al. Working Group on Sepsis-Related

Problems of the European Society of Intensive Care Medicine.

The SOFA (Sepsis-related Organ Failure Assessment) score

to describe organ dysfunction/failure. Intensive Care Med. 1996;

(7):707–710.

Vincent JL, de Mendonça A, Cantraine F, et al. Working Group on

“Sepsis-Related Problems” of the European Society of Intensive

Care Medicine. Use of the SOFA score to assess the incidence of

organ dysfunction/failure in intensive care units: results of a multicenter,

prospective study. Crit Care Med. 1998; 26(11):1793–1800.

[PubMed: 9824069].

Vincent J-L, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions:

time for change. Lancet. 2013; 381(9868):774–775.

Rosser, C.J., et al. Urinary tract infections in the critically ill patient

with a urinary catheter. Am J Surg, 1999. 177: 287.

Martin, G.S., et al. The epidemiology of sepsis in the United States

from 1979 through 2000. N Engl J Med, 2003. 348: 1546.

Hotchkiss, R.S., et al. The pathophysiology and treatment of sepsis.

N Engl J Med, 2003. 348: 138.

Brun-Buisson, C., et al. EPISEPSIS: a reappraisal of the epidemiology

and outcome of severe sepsis in French intensive care units.

Intensive Care Med, 2004. 30: 580.

Tandogdu, Z., et al. Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections

in urology (GPIU) study 2003-2013. World J Urol, 2016. 34: 1193.

Meakins JL, Pietsch JB, Bubenick O, et al. Delayed hypersensitivity:

indicator of acquired failure of host defenses in sepsis and trauma.

Ann Surg 1977;186:241-50.

Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the

adaptive immune response. Shock 1999;11:153-9.

Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes:

understanding the role of innate and acquired immunity. Shock

;16:83-96.

O’Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick

ML. Major injury leads to predominance of the T helper-2

lymphocyte phenotype and diminished interleukin-12 production

associated with decreased resistance to infection. Ann Surg

;222:482-92.

Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death

in patients with sepsis, shock, and multiple organ dysfunction. Crit

Care Med 1999;27:1230-51.

Hotchkiss RS, Tinsley KW, Swanson PE, et al. Sepsis-induced apoptosis

causes progressive profound depletion of B and CD4+ T

lymphocytes in humans. J Immunol 2001; 166:6952-63.

Hotchkiss RS, Tinsley KW, Swanson PE, et al. Depletion of dendritic

cells, but not macrophages, in patients with sepsis. J Immunol

;168:2493-500.

Fukuzuka K, Edwards CK III, ClareSalzler M, Copeland EM III, Moldawer

LL, Mozingo DW. Glucocorticoid-induced, caspase-dependent

organ apoptosis early after burn injury. Am J Physiol Regul Integr

Comp Physiol 2000;278:R1005-R1018.

Ayala A, Herdon CD, Lehman DL, DeMaso CM, Ayala CA, Chaudry

IH. The induction of accelerated thymic programmed cell death

during polymicrobial sepsis: control by corticosteroids but not

tumor necrosis factor. Shock 1995;3:25967.

Thomas L. Germs. N Engl J Med 1972; 287:553-5.

Munford RS, Pugin J. Normal responses to injury prevent systemic

inflammation and can be immunosuppressive. Am J Respir Crit

Care Med 2001;163:316-21.

69. Freeman BD, Buchman TG. Gene in a haystack: tumor necrosis

factor polymorphisms and outcome in sepsis. Crit Care Med

;28:3090-1.

Kollef MH, Schuster DP. The acute respiratory distress syndrome.

N Engl J Med 1995;332:27-37.

Levy B (2006) Lactate and shock state: the metabolic view. Curr

Opin Crit Care. 12(4):315–321.

Cecconi M, De Backer D, Antonelli M et al (2014) Consensus on

circulatory shock and hemodynamic monitoring. Task force of the

European Society of Intensive Care Medicine. Intensive Care Med

(12):1795–1815.

Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy

in the treatment of severe sepsis and septic shock. N Engl J Med

; 345:1368 –1377.

Peake SL, Delaney A, Bailey M et al (2014) Goal‑directed resuscitation

for patients with early septic shock. N Engl J Med

(16):1496–1506.

Yealy DM, Kellum JA, Huang DT et al (2014) A randomized trial

of protocol‑based care for early septic shock. N Engl J Med

(18):1683–1693.

Mouncey PR, Osborn TM, Power GS et al (2015) Trial of early,

goal‑directed resuscitation for septic shock. N Engl J Med

(14):1301–1311.

Eskesen TG, Wetterslev M, Perner A (2016) Systematic review

including re‑analyses of 1148 individual data sets of central venous

pressure as a predictor of fluid responsiveness. Intensive Care Med

(3):324–332.

Lamontagne F, Meade MO, Hebert PC et al (2016) Higher versus

lower blood pressure targets for vasopressor therapy in shock: a

multicenter pilot randomized controlled trial. Intensive Care Med

(4):542–550.

Zadroga R, Williams DN, Gottschall R et al (2013) Comparison of

blood culture media shows significant differences in bacterial

recovery for patients on antimicrobial therapy. Clin Infect Dis

(6):790–797.

Kanegaye JT, Soliemanzadeh P, Bradley JS (2001) Lumbar puncture

in pediatric bacterial meningitis: defining the time interval

for recovery of cerebrospinal fluid pathogens after parenteral

antibiotic pretreatment. Pediatrics 108(5):1169–1174.

Pollack LA, van Santen KL, Weiner LM, Dudeck MA, Edwards JR,

Srinivasan A (2016) Antibiotic stewardship programs in U.S. acute

care hospitals: findings from the 2014 National Healthcare Safety

Network Annual Hospital Survey. Clin Infect Dis. 63(4):443–449.

Garnacho‑Montero J, Gutiérrez‑Pizarraya A, Escoresca‑Ortega A

et al (2013) De‑escalation of empirical therapy is associated with

lower mortality in patients with severe sepsis and septic shock.

Intensive Care Med 40(1):32‑40.

Weiss CH, Persell SD, Wunderink RG, Baker DW (2012) Empiric

antibiotic mechanical ventilation, and central venous catheter

duration as potential factors mediating the effect of a checklist

prompting intervention on mortality: an exploratory analysis.

BMC Health Serv Res. 12(1):1.

Weinstein MP, Reller LB, Murphy JR, Lichtenstein KA (1983) The

clinical significance of positive blood cultures: a comprehensive

analysis of 500 episodes of bacteremia and fungemia in adults.

I. Laboratory and epidemiologic observations. Rev Infect Dis

(1):35–53.

Li J, Plorde JJ, Carlson LG (1994) Effects of volume and periodicity

on blood cultures. J Clin Microbiol 32(11):2829–2831.

Baron EJ, Miller JM, Weinstein MP et al (2013) A guide to utilization

of the microbiology laboratory for diagnosis of infectious diseases:

recommendations by the Infectious Diseases Society of America

(IDSA) and the American Society for Microbiology (ASM)(a).

Clin Infect Dis 57(4):e22–e121.

Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension

before initiation of effective antimicrobial therapy is the critical

determinant of survival in human septic shock. Crit Care Med

(6):1589–1596.

Ferrer R, Martin‑Loeches I, Phillips G et al (2014) Empiric antibiotic

treatment reduces mortality in severe sepsis and septic shock

from the first hour: results from a guideline‑based performance

improvement program. Crit Care Med 42(8):1749–1755.

Bagshaw SM, Lapinsky S, Dial S et al (2009) Acute kidney injury

in septic shock: clinical outcomes and impact of duration of hypotension

prior to initiation of antimicrobial therapy. Intensive

Care Med 35(5):871–881.

Iscimen R, Cartin‑Ceba R, Yilmaz M et al (2008) Risk factors for the

development of acute lung injury in patients with septic shock:

an observational cohort study. Crit Care Med 36(5):1518–1522.

Garnacho‑Montero J, Aldabo‑Pallas Garnacho‑Montero C et al

(2006) Timing of adequate antibiotic therapy is a greater determinant

of outcome than are TNF and IL‑10 polymorphisms in

patients with sepsis Crit Care 10(4):R111.

Romanelli G, Cravarezza P, Group IIMS (1995) Intramuscular

meropenem in the treatment of bacterial infections of the urinary

and lower respiratory tracts. J Antimicrob Chemother 36(suppl

A):109–119.

Cormio L, Berardi B, Callea A et al (2002) Antimicrobial prophylaxis

for transrectal prostatic biopsy: a prospective study of ciprofloxacin

vs piperacillin/tazobactam. BJU Int 90(7):700–702.

Barbhaiya RH, Knupp CA, Tenney J, Martin RR, Weidler DJ, Pittman

KA (1990) Safety, tolerance, and pharmacokinetics of cefepime

administered intramuscularly to healthy subjects. J Clin Pharmacol

(10):900–910.

Green DL (2005) Selection of an empiric antibiotic regimen for

hospital‑acquired pneumonia using a unit and culture‑type specific

antibiogram. J Intensive Care Med. 20(5):296–301.

Kaufman D, Haas CE, Edinger R, Hollick G (1998) Antibiotic susceptibility

in the surgical intensive care unit compared with the

hospital‑wide antibiogram. Arch Surg 133(10):1041–1045.

Kerremans JJ, Verbrugh HA, Vos MC (2012) Frequency of microbiologically

correct antibiotic therapy increased by infectious disease consultations

and microbiological results. J Clin Microbiol 50(6):2066–2068.

Raineri E, Pan A, Mondello P, Acquarolo A, Candiani A, Crema L

(2008) Role of the infectious diseases specialist consultant on

the appropriateness of antimicrobial therapy prescription in an

intensive care unit. Am J Infect Control 36(4):283–290.

Bai AD, Showler A, Burry L et al (2015) Impact of infectious disease

consultation on quality of care, mortality, and length of stay in

Staphylococcus aureus bacteremia: results from a large multicenter

cohort study. Clin Infect Dis 60(10):1451–1461.

Moore RD, Smith CR, Lietman PS (1984) Association of aminoglycoside

plasma levels with therapeutic outcome in gram‑negative

pneumonia. Am J Med 77(4):657–662.

Men P, Li HB, Zhai SD, Zhao RS (2016) Association between the

AUC0‑24/MIC ratio of vancomycin and its clinical effectiveness: a

systematic review and meta‑analysis. PLoS One 11(1):e0146224.

Moise‑Broder PA, Forrest A, Birmingham MC, Schentag JJ (2004)

Pharmacodynamics of vancomycin and other antimicrobials in

patients with Staphylococcus aureus lower respiratory tract infections.

Clin Pharmacokinet 43(13):925–942.

Zelenitsky S, Rubinstein E, Ariano R et al (2013) Vancomycin pharmacodynamics

and survival in patients with methicillin‑resistant

Staphylococcus aureus associated septic shock. Int J Antimicrob

Agents 41(3):255–260.

Kalil AC, Metersky ML, Klompas M et al (2016) Management of

adults with hospital‑acquired and ventilator‑associated pneumonia:

Clin ical Practice Guidelines by the Infectious Diseases

Society of America and the American Thoracic Society. Clin Infect

Dis 63(5):e61–e111.

Chastre J, Wolff M, Fagon JY et al (2003) Comparison of 8 vs 15

days of antibiotic therapy for ventilator‑associated pneumonia in

adults: a randomized trial. JAMA 290(19):2588–2598.

Choudhury G, Mandal P, Singanayagam A, Akram AR, Chalmers JD,

Hill AT (2011) Seven‑day antibiotic courses have similar efficacy to

prolonged courses in severe community‑acquired pneumonia‑a propensity‑adjusted

analysis. Clin Microbiol Infect 17(12):1852–1858.

Pugh R, Grant C, Cooke RP, Dempsey G (2015) Short‐course versus

prolonged‐course antibiotic therapy for hospital‐acquired

pneumonia in critically ill adults. Cochrane Database Syst Rev

:CD007577.

Schuetz P, Briel M, Christ‑Crain M et al (2012) Procalcitonin to guide

initiation and duration of antibiotic treatment in acute respiratory

infections: an individual patient data meta‑analysis. Clin Infect

Dis 55(5):651–662.

Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A,

Dimopoulos G (2012) An ESICM systematic review and meta‑analysis

of procalcitonin‑guided antibiotic therapy algorithms in adult

critically ill patients. Intensive Care Med 38(6):940–949.

Prkno A, Wacker C, Brunkhorst FM, Schlattmann P (2013) Procalcitonin

guided therapy in intensive care unit patients with severe

sepsis and septic shock–a systematic review and meta‑analysis.

Crit Care 17(6):R291.

Westwood M, Ramaekers B, Whiting P et al (2015) Procalcitonin

testing to guide antibiotic therapy for the treatment of sepsis in

intensive care settings and for suspected bacterial infection in

emergency department settings: a systematic review and cost‑effectiveness

analysis. Health Technol Assess 19(96):v–xxv, 1–236.

Wacker C, Prkno A, Brunkhorst FM, Schlattmann P (2013) Procalcitonin

as a diagnostic marker for sepsis: a systematic review and

meta‑analysis. Lancet Infect Dis. 13(5):426–435.

Soni NJ, Samson DJ, Galaydick JL et al (2013) Procalcitonin‑guided

antibiotic therapy: a systematic review and meta‑analysis. J Hosp

Med. 8(9):530–540.

Acheampong A, Vincent JL (2015) A positive fluid balance is an

independent prognostic factor in patients with sepsis. Crit Care

:251.

Brotfain E, Koyfman L, Toledano R et al (2016) Positive fluid balance

as a major predictor of clinical outcome of patients with sepsis/septic

shock after ICU discharge. Am J Emerg Med 34(11):2122–2126.

Mitchell KH, Carlbom D, Caldwell E, Leary PJ, Himmelfarb J, Hough

CL (2015) Volume overload: prevalence, risk factors, and functional

outcome in survivors of septic shock. Ann Am Thorac Soc.

(12):1837–1844.

De Oliveira FS, Freitas FG, Ferreira EM et al (2015) Positive fluid

balance as a prognostic factor for mortality and acute kidney injury

in severe sepsis and septic shock. J Crit Care 30(1):97–101.

Malbrain ML, Marik PE, Witters I et al (2014) Fluid overload, de‑resuscitation,

and outcomes in critically ill or injured patients: a systematic

review with suggestions for clinical practice. Anaesthesiol

Intensive Ther. 46(5):361–380.

Finfer S, Norton R, Bellomo R, Boyce N, French J, Myburgh J (2004)

The SAFE study: saline vs. albumin for fluid resuscitation in the

critically ill. Vox Sang 87(Suppl 2):123–131.

Delaney AP, Dan A, McCaffrey J, Finfer S (2011) The role of albumin

as a resuscitation fluid for patients with sepsis: a systematic review

and meta‑analysis. Crit Care Med 39(2):386–391.

Day NP, Phu NH, Bethell DP et al (1996) The effects of dopamine

and adrenaline infusions on acid‑base balance and systemic haemodynamics

in severe infection. Lancet 348(9022):219–223.

De Backer D, Creteur J, Silva E, Vincent JL (2003) Effects of dopamine

norepinephrine, and epinephrine on the splanchnic circulation in

septic shock: which is best? Crit Care Med 31(6):1659–1667.

Yamazaki T, Shimada Y, Taenaka N, Oshumi H, Takezawa J, Yoshiya

I (1982) Circulatory responses to afterloading with phenylephrine

in hyperdynamic sepsis. Crit Care Med 10(7):432–435.

Avni T, Lador A, Lev S, Leibovici L, Paul M, Grossman A (2015)

Vasopressors for the treatment of septic shock: systematic review

and meta‑ analysis. PLoS One 10(8):e0129305.

Cohn JN (1967) Blood pressure measurement in shock. Mechanism

of inaccuracy in ausculatory and palpatory methods. JAMA

(13):118–122.

Sprung CL, Annane D, Keh D et al (2008) Hydrocortisone therapy

for patients with septic shock. N Engl J Med 358(2):111–124.

Sligl WI, Milner DA Jr, Sundar S, Mphatswe W, Majumdar SR (2009)

Safety and efficacy of corticosteroids for the treatment of septic

shock a systematic review and meta‑analysis. Clin Infect Dis

(1):93–101.

Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y

(2015) Corticosteroids for treating sepsis. Cochrane Database Syst

Rev 12:CD002243.

Volbeda M, Wetterslev J, Gluud C, Zijlstra JG, van der Horst IC, Keus

F (2015) Glucocorticosteroids for sepsis: systematic review with

meta‑analysis and trial




DOI: http://dx.doi.org/10.19264/hj.v30i3.237